Ireland: Vitalograph acquires Morgan Scientific to meet growing demand for respiratory diagnostic solutions

Vitalograph, a global provider of respiratory diagnosticsolutions and clinical drug trialservices. has acquired long-term partner, US-based Morgan Scientific, strengthening its US commercial footprint and enabling it...

UK: BGF reports strong returns as it exits partnership with Springfield Healthcare Group

BGF has secured a strong return on its investment in Springfield Healthcare Group, according to the UK-based investor in small and mid-sized businesses as it...

Germany: Allgaier Instrumente acquired by Ackermann Instrumente

Ackermann Instrumente, a manufacturer of surgical solutions, has acquired Allgaier Instrumente, a Frittlingen-based manufacturer of specialty instrumentation across various clinical disciplines. The acquisition augments...

UK: PMI subsidiary sells Vectura Group to Molex Asia Holdings

Vectura Fertin Pharma, an affiliate of tobacco company Philip Morris International (PMI), has sold subsidiary UK-based Vectura Group to Molex Asia Holdings, and the establishment of master...

Switzerland: Viromed Medical to acquire ActivCell Group

Germany-based biotech company, Viromed Medical, has announced plans to acquire all shares in Switzerland-based ActivCell Group. With the acquisition Viromed expands its range of...

France: Valneva raises €61.18m in private placement

Valneva, a specialty vaccine company, has raised €61.18m (US$68m) in a private placement of shares. A total of 23,000,000 new ordinary shares were issued...

Germany: Cinven to sell minority stake in Synlab to strategic investor Labcorp

Private equity firm, Cinven, is selling an indirect minority stake in Synlab, a medical diagnostic services and specialty testing company in Europe, to strategic...

Italy: De Agostini makes first investment in the pharmaceutical sector

De Agostini, the industrial and financial holding company controlled by the Boroli and Drago families, has acquired the Content Group, an Italy-based CDMO, from...

4BIO Capital – Investing in a future where advanced therapies are the standard

London-based venture capital firm, 4BIO Capital, believes in a future where advanced therapies are the standard of care. Founded in 2015, the firm has built...

UK: F2G announces US$100m financing to advance late-stage development and commercialization of Olorofim in...

F2G, a UK-based clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening rare fungal infections, has announced a...
Advertisement